(-) -Enitociclib
(-) -Enitociclib ((R) -Enitociclib) is an enantiomer of Enitociclib (HY-103019E) with an optical rotation of (-) . Enitociclib is a selective CDK9 inhibitor and apoptosis inducer. Enitociclib inhibits CDK9 activity and reduces the phosphorylation of Ser2 in the carboxyl-terminal domain (CTD) of RNA polymerase Pol II, thereby downregulating the transcription of key oncogenes such as MYC and MCL1. Enitociclib has anti-proliferative activity targeting MYC+ lymphoma and multiple myeloma (MM) cells, and has synergistic effects with Bortezomib (HY-10227) and Lenalidomide (HY-A0003), and can be used in the research of hematological malignancies[1][2].
Product Specifications
CAS Number
[1610408-96-2]
Product Name Alternative
(R) -Enitociclib; (-) -BAY-1251152; (-) -VIP152
UNSPSC
12352005
Target
Apoptosis; CDK; DNA/RNA Synthesis; Drug Isomer
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/minus-enitociclib.html
Purity
99.85
Solubility
DMSO : 22 mg/mL (ultrasonic)
Smiles
COC1=C(C2=C(F)C=NC(NC3=CC(C[S@](C)(=N)=O)=CC=N3)=C2)C=CC(F)=C1
Molecular Formula
C19H18F2N4O2S
Molecular Weight
404.43
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-103019B/minus-Enitociclib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-103019B/minus-Enitociclib-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
CDK9
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![KRT20 Antibody (C-term) [APR04605G]](https://cdn.genprice.uk/genprice/genprice3.png)
![KRT20 Antibody (C-term) [APR04605G]](https://cdn.genprice.uk/genprice/genprice2.png)
